Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.95% | 20.64k | 199.76k |
| Vanguard Total Stock Market Index Fund | 0.78% | 16.84k | 163.01k |
| Fidelity Extended Market Index Fund | 0.41% | 8.98k | 86.97k |
| Fidelity NASDAQ Composite Index Fund | 0.14% | 2.95k | 28.59k |
| Fidelity NASDAQ Composite Index ETF | 0.14% | 2.94k | 28.49k |
| Fidelity Total Market Index Fund | 0.13% | 2.78k | 26.9k |
| Vanguard Institutional Index-Inst Total Stock Market Ind | 0.08% | 1.7k | 16.49k |
| Fidelity Series Total Market Index Fund | 0.07% | 1.61k | 15.55k |
| iShares Core S&P Total U.S. Stock Market ETF | 0.05% | 1.13k | 10.95k |
| Vanguard Balanced Index Fund | 0.02% | 440 | 4.26k |
Global Mucopolysaccharidosis Treatment Market to Witness Robust Growth, Projected to Reach USD 5,014.5 Million by 2035 Growing at a CAGR of 5.9% | FMI
01/02 03:30 am
GlobeNewswire Inc.
Read moreComprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight
12/19 02:00 pm
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals secures $3.2 million in additional funding - Investing.com
07/16 05:54 pm
Investing.com
Read moreEloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program Updates
04/16 07:30 am
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
09/07 09:00 am
GlobeNewswire Inc.
Read moreWhy 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
08/14 12:49 pm
Benzinga
Read moreEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement
08/03 09:26 am
GlobeNewswire Inc.
Read moreWhy Senmiao Technology Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
07/13 08:12 am
Benzinga
Read moreWhy ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
07/12 08:19 am
Benzinga
Read moreTop Penny Stocks Today? Why ELOX Stock Is Skyrocketing & 3 More To Watch
07/11 03:06 pm
PennyStocks
Read moreEloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome
06/21 01:30 pm
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients
06/14 04:53 pm
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement
06/06 08:30 am
GlobeNewswire Inc.
Read moreGold Down 1.5%; Baidu Earnings Top Estimates
05/16 02:31 pm
Benzinga
Read moreNasdaq Edges Higher; Home Depot Posts Downbeat Sales
05/16 12:31 pm
Benzinga
Read moreDow Tumbles Over 200 Points; US Retail Sales Rise In April
05/16 10:35 am
Benzinga
Read moreSenesco Technologies Inc. (ELOX) Reports Q1 Loss, Lags Revenue Estimates
05/15 05:55 pm
Zacks Investment Research
Read moreEloxx Pharmaceuticals Reports First Quarter 2023 Financial and Operating Results and Provides Business Update
05/15 04:30 pm
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals Announces Submission of Investigational New Drug (IND) Application for ZKN-013
03/28 04:45 pm
GlobeNewswire Inc.
Read moreAre Medical Stocks Lagging Elevation Oncology (ELEV) This Year?
03/23 09:40 am
Zacks Investment Research
Read moreEloxx Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
03/06 05:10 pm
GlobeNewswire Inc.
Read moreSenesco Technologies Inc. (ELOX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
02/28 10:55 am
Zacks Investment Research
Read more5 Hot Penny Stocks Exploding After News This Week
01/05 10:39 am
PennyStocks
Read moreEloxx Pharmaceuticals Announces Reverse Stock Split Effective
12/01 09:45 am
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals Reports Third Quarter 2022 Financial and Operating Results and Provides Business Update
11/10 06:15 pm
GlobeNewswire Inc.
Read moreEloxx Pharmaceuticals Announces Opening of Clinical Trial Sites for Phase 2 Study of ELX-02 for the Treatment of Alport Syndrome
11/01 04:30 pm
GlobeNewswire Inc.
Read moreWhy Twin Vee Powercats Is Trading Lower By Over 30%; Here Are 30 Stocks Moving Premarket
09/29 06:55 am
Benzinga
Read moreBiotech Stock Roundup: GILD, BMY's Regulatory News, BLUE's Therapy Approval & More
09/22 12:17 pm
Zacks Investment Research
Read moreEloxx (ELOX) Down After Cystic Fibrosis Study Fails to Meet Goal
09/16 11:42 am
Zacks Investment Research
Read moreWhy ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
09/16 04:38 am
Benzinga
Read moreS&P 500 Down 0.6%; Crude Oil Falls Sharply
09/15 02:42 pm
Benzinga
Read moreWhy Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
09/15 01:03 pm
Benzinga
Read moreUS Stocks Turn Lower; Nasdaq Drops Over 100 Points
09/15 12:04 pm
Benzinga
Read moreEloxx Pharmaceuticals Reports Topline Results from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients
09/14 04:05 pm
GlobeNewswire Inc.
Read moreWhy Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday
08/29 02:55 am
Benzinga
Read moreWhy NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
08/05 06:12 am
Benzinga
Read more